483 Glenmark Pharmaceuticals May 2018

483 Glenmark Pharmaceuticals May 2018

Arsen Karapetyan FDA, Pratik Upadhyay FDA$119.00 - Available Now

FDA investigators audited the Glenmark Pharmaceuticals - Pithampur, Dhar, India facility and issued inspectional observations (via FDA 483) on 24 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 24 May 2018
  • Location: Pithampur, Dhar, India
  • FEI: 3008565058
Add To Cart